Sugi Predict

Sugi Predict / Targets / HNRNPAB

HNRNPAB

Heterogeneous nuclear ribonucleoprotein A/B · Q99729 · HNRNPAB on Sugi Atlas →

0 patent compounds predicted against HNRNPAB, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to HNRNPAB by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Preventive Approach to Congenital Heart Block With Hydroxychloroquine PHASE2COMPLETED
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Immunophenotyping and Xist Gene in AML nanUNKNOWN
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life nanCOMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
Risk of HCC in Cirrhotic Patients Post DAAs Ttt nanUNKNOWN
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Identification of New FTLD Genes nanUNKNOWN
Clinical and Genetic Examinations of Dilated Cardiomyopathy nanCOMPLETED
International PPB/DICER1 Registry nanRECRUITING
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia nanNOT_YET_RECRUITING
Genetics of Familial and Sporadic ALS nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a HNRNPAB binder may also engage these)

ProteinNameSimilarity
Q5ZI72 — 1.000 Q5ZI72 →
HNRNPD Heterogeneous nuclear ribonucleoprotein D0 1.000 landscape →
Q3SWU3 — 0.999 Q3SWU3 →
Q9JJ54 — 0.996 Q9JJ54 →
Q640A2 — 0.996 Q640A2 →
Q60668 — 0.995 Q60668 →
Q7ZX83 — 0.993 Q7ZX83 →
Q9Z130 — 0.992 Q9Z130 →
Q99020 — 0.992 Q99020 →
Q7TP47 — 0.992 Q7TP47 →
Q6NU14 — 0.991 Q6NU14 →
Q7TMK9 — 0.990 Q7TMK9 →
SYNCRIP Heterogeneous nuclear ribonucleoprotein Q 0.989 landscape →
Q32P51 — 0.989 Q32P51 →
HNRNPA0 Heterogeneous nuclear ribonucleoprotein A0 0.988 landscape →
Q22037 — 0.987 Q22037 →
Q9CX86 — 0.987 Q9CX86 →
Q5RBU8 — 0.985 Q5RBU8 →
A7VJC2 — 0.985 A7VJC2 →
HNRNPR Heterogeneous nuclear ribonucleoprotein R 0.984 landscape →
A2Q848 — 0.984 A2Q848 →
HNRNPDL Heterogeneous nuclear ribonucleoprotein D-like 0.984 landscape →
DAZAP1 DAZ-associated protein 1 0.984 landscape →
P21522 — 0.983 P21522 →
MSI2 RNA-binding protein Musashi homolog 2 0.982 landscape →
Q28521 — 0.982 Q28521 →
HNRNPA3 Heterogeneous nuclear ribonucleoprotein A3 0.982 landscape →
Q98SJ2 — 0.982 Q98SJ2 →
Q0CR95 — 0.982 Q0CR95 →
Q9NFU0 — 0.982 Q9NFU0 →